Form D · Other

Medmo, Inc.

New York, NY · CIK 0001724863

Offering snapshot reported Oct 14, 2025 · SEC filing

Reported sold
$14.6M
Offering amount: $14.6M
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 6, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 14, 2025Initial$14,621,048No comparison12SEC filing
Feb 18, 2025Initial$4,621,050No comparison11SEC filing
Oct 26, 2023Initial$4,999,982No comparison13SEC filing
Aug 10, 2022Initial$1,610,000No comparison12SEC filing
Aug 11, 2021Initial$2,700,000No comparisonNot reportedSEC filing
Jan 4, 2021Initial$3,000,000No comparison1SEC filing
Sep 18, 2019Initial$70,000No comparison2SEC filing
May 1, 2018Initial$150,000No comparison2SEC filing
Feb 7, 2018Initial$25,000No comparison2SEC filing
Dec 15, 2017Initial$50,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-560732
Total Offering Amount includes the conversion of $4,621,050.00 in convertible securities previously issued by the Company.

Source: Form D, filed Oct 14, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Alex Dikman Director
Robert Epstein Director
Christopher Kelly Director
Gadi Porat Director
Lucas Takahashi Director, Executive, Promoter

Issuer details

Industry: Other (See others in industry)

Address:
122 Grand Street
New York, NY, 10013